Profile data is unavailable for this security.
About the company
AegirBio AB is a Sweden-based medicine company focused therapeutic drug monitoring of biologic therapies in the autoimmune, oncology and neurology space. The Company offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. It aims to provide personalized treatment by tracking drugs levels in individuals. Aegirbio combines core technologies from LifeAssays and Abreos Biosciences. LifeAssays is a diagnostics company based in Sweden, which owns the Magnia Point of Care and Point of Need reader technology. Abreos Biosciences is a California-based biotech, which is a developer of the Veritope chemistry platform for detecting levels of biologic drugs in patient samples.
- Revenue in SEK (TTM)36.00k
- Net income in SEK-49.38m
- Incorporated2019
- Employees14.00
- LocationAegirbio ABScheelevagen 27LUND 22363SwedenSWE
- Websitehttps://aegirbio.com/